LAG3 and neoplasm: In another recent report, Zahm et al. 2021, used an OVA-expressing mouse tumor model, to show that CD8 + T cells activated in the presence of APCs expressed multiple checkpoint receptors; but T cells activated without APCs expressed LAG-3 alone, suggesting that LAG-3 might be a preferred target in combination with vaccination.